Stifel Financial
CLB icon

Stifel Financial’s Core Laboratories CLB Stock Holding History

Stifel Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
+25,092
New +$358K ﹤0.01% 3302
2024
Q3 		– Sell
-14,740
Closed -$299K – 3377
2024
Q2 		$299K Buy
14,740
+1,832
+14% +$32.4K ﹤0.01% 2918
2024
Q1 		$220K Buy
+12,908
New +$203K ﹤0.01% 3054
2023
Q4 		– Sell
-8,970
Closed -$215K – 3337
2023
Q3 		$215K Buy
+8,970
New +$220K ﹤0.01% 2955
2020
Q1 		– Sell
-51,224
Closed -$1.94M – 2855
2019
Q4 		$1.94M Buy
51,224
+1,070
+2% +$48.1K ﹤0.01% 1354
2019
Q3 		$2.36M Buy
50,154
+6,477
+15% +$301K 0.01% 1208
2019
Q2 		$2.29M Sell
43,677
-15,754
-27% -$924K 0.01% 1250
2019
Q1 		$4.08M Sell
59,431
-10,379
-15% -$696K 0.01% 895
2018
Q4 		$4.15M Sell
69,810
-42,585
-38% -$3.67M 0.01% 849
2018
Q3 		$13M Sell
112,395
-2,118
-2% -$239K 0.04% 430
2018
Q2 		$14.5M Sell
114,513
-2,736
-2% -$333K 0.04% 410
2018
Q1 		$12.7M Buy
117,249
+14,904
+15% +$1.65M 0.04% 443
2017
Q4 		$11.2M Buy
102,345
+6,400
+7% +$639K 0.04% 486
2017
Q3 		$9.5M Buy
95,945
+14,322
+18% +$1.39M 0.03% 526
2017
Q2 		$8.26M Buy
81,623
+2,128
+3% +$229K 0.03% 545
2017
Q1 		$9.18M Buy
79,495
+1,913
+2% +$222K 0.04% 484
2016
Q4 		$9.32M Sell
77,582
-8,274
-10% -$916K 0.04% 436
2016
Q3 		$9.64M Buy
85,856
+11,781
+16% +$1.36M 0.04% 388
2016
Q2 		$9.17M Buy
74,075
+137
+0.2% +$16.5K 0.04% 389
2016
Q1 		$8.31M Sell
73,938
-16,603
-18% -$1.72M 0.04% 370
2015
Q4 		$9.85M Sell
90,541
-3,360
-4% -$385K 0.05% 351
2015
Q3 		$9.34M Buy
93,901
+3,637
+4% +$396K 0.05% 355
2015
Q2 		$10.2M Buy
90,264
+14,333
+19% +$1.74M 0.05% 360
2015
Q1 		$7.94M Buy
75,931
+13,080
+21% +$1.39M 0.04% 469
2014
Q4 		$7.55M Buy
62,851
+53,502
+572% +$7.03M 0.04% 475
2014
Q3 		$1.37M Sell
9,349
-6,053
-39% -$934K 0.01% 941
2014
Q2 		$2.57M Buy
15,402
+7,395
+92% +$1.32M 0.02% 673
2014
Q1 		$1.59M Buy
+8,007
New +$1.51M 0.02% 831

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Stifel Financial's CLB Position: Q2 2026 in Review

Stifel Financial opened a new position in Core Laboratories (CLB) in Q2 2026: 25,092 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #3302 among its holdings. This is a return to the name: Stifel Financial previously reported a position in CLB as recently as Q2 2024.

Stifel Financial first reported a position in CLB in Q1 2014 and has held it in 28 quarters since. The position peaked at $14.5M in Q2 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Stifel Financial held 25,092 shares of Core Laboratories worth $292K as of Q2 2026.
  • Core Laboratories was a new Stifel Financial position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3302 holding.
  • Stifel Financial first reported a position in Core Laboratories in Q1 2014 and has held it in 28 quarters since.
  • Stifel Financial's Core Laboratories position peaked at $14.5M in Q2 2018.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.